Table 4.
Pre-treatment | Post-treatment | ||||||
Treatment (65) | Control (65) | Treatment (55) | Control (53) | ||||
Variable | No. (%) | No. (%) | χ2 | No. (%) | No. (%) | χ2 | P |
Fears | 48 (73.85) | 46 (70.77) | 0.154 | 30 (54.55) | 40 (75.47) | 5.183 | .023 |
Sleep/insomnia | 44 (67.69) | 45 (69.30) | 0.036 | 21 (38.18) | 39 (73.58) | 13.701 | .000 |
Memory decline | 35 (53.85) | 33 (50.77) | 0.123 | 29 (52.73) | 28 (52.83) | 0.000 | .988 |
Nervous, anxiety | 34 (52.31) | 35 (53.85) | 0.031 | 17 (30.91) | 27 (50.94) | 4.487 | .034 |
Fatigue | 46 (70.77) | 41 (63.08) | 0.869 | 39 (70.91) | 42 (79.25) | 1.000 | .317 |
Pain | 38 (58.46) | 37 (56.92) | 0.032 | 41 (74.55) | 36 (67.92) | 0.578 | .447 |
Insurance/financial | 39 (60.00) | 41 (63.08) | 0.130 | 42 (76.36) | 38 (70.70) | 0.306 | .580 |
Loss of appetite | 31 (47.69) | 33 (50.77) | 0.123 | 15 (27.27) | 30 (56.60) | 9.554 | .002 |
Nausea/vomiting | 29 (44.62) | 26 (40.00) | 0.284 | 28 (50.91) | 25 (47.17) | 0.151 | .698 |
Tingling hands/feet | 26 (40.00) | 25 (38.46) | 0.032 | 28 (50.91) | 24 (45.28) | 0.342 | .559 |